Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
|更新时间:2023-05-17
|
Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
Chinese Journal of Experimental Traditional Medical FormulaeVol. 29, Issue 7, Pages: 185-192(2023)
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192.
XIE Junjie,TAN Peng,ZHENG Chuan,et al.Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(07):185-192. DOI: 10.13422/j.cnki.syfjx.20220758.
Establishment and Application of Rapid Screening Method for Influenza Virus Neuraminidase Inhibitors Sourced from Traditional Chinese Medicine Based on Fluorescence Detection
To establish a rapid screening method for influenza virus neuraminidase(NA) inhibitors sourced from Chinese medicines based on fluorescence detection.
Method
2
The method was constructed based on the principle that after the reaction of the test sample and a certain amount of NA, the activity of some NA will be inhibited by the test sample, and the NA that is still active after the addition of the substrate can generate fluorescence at a specific wavelength when combined with the fluorescent substrate, and the inhibition rate of the test sample on NA was calculated according to the measured fluorescence intensity, so as to evaluate the
in vitro
inhibitory activity of the test sample on NA. A total of 49 high-purity chemical components from 12 Chinese medicines were used to evaluate the
in vitro
anti-NA activity by the established method. The theoretical calculated values of binding energy and inhibition constant after docking between the NA protein receptor and the test sample were used to prove the accuracy of the experimental results. The established method was applied to detect the
in vitro
NA inhibitory activity of different batches of Banlangen granules and Kangbingdu granules, so as to evaluate the quality consistency among different batches of samples.
Result
2
The methodological examination results showed that the method had good accuracy and repeatability. The screening results of 49 components showed that 22 of them had strong
in vitro
inhibitory activity against NA than peramivir [half inhibitory concentration(IC
50
) was 131.2 μmol·L
-1
], such as schaftoside, isoorientin, chebulinic acid, menthone and isoschaftoside. The inhibitory activity of the remaining 27 components was weaker than that of peramivir. The molecular docking results showed that the theoretical calculation results of binding energies and inhibition constants of most compounds were basically consistent with the experimental results. The test results of the inhibitory activity of 12 batches of Banlangen granules on NA showed that the quality consistency among samples A1, A2, B2, C1, C2, E2 and F2 was good. The analysis results of the inhibitory activity of 9 batches of Kangbingdu granules produced by the same manufacturer on NA showed that the inhibitory rates of samples K1 to K9 were 37.68%, 36.18%, 31.37%, 33.98%, 40.36%, 33.76%, 40.69%, 41.08%, 40.06% when the concentration of 0.02 g·mL
-1
, and the average inhibitory rate was 37.24%.
Conclusion
2
In this paper, we successfully established an analytical method that can be used to rapidly evaluate whether Chinese medicines (derived from chemical components of traditional Chinese medicine or proprietary Chinese medicines) have
in vitro
anti-NA activity, which can be a powerful supplement to the existing screening methods for influenza virus NA inhibitors. And this method was used to screen 22 compounds from 12 Chinese medicines with good
in vitro
inhibitory activity against NA, which can provide candidate compounds for the development of anti-influenza small molecule drugs.
MARR L C,TANG J W,VAN-MULLEKOM J,et al.Mechanistic insights into the effect of humidity on airborne influenza virus survival,transmission and incidence[J].J R Soc Interface,2019,16(150):20180298.
JACKSON M L,CHUNG J R,JACKSON L A,et al.Influenza vaccine effectiveness in the united states during the 2015—2016 season[J].N Engl J Med,2017,377(6):534-543.
PENG X Y,XIAO Y C,LI L,et al.Curative efficacy and safety of peramivir in the treatment of children suspected with influenza[J].Eur J Inflamm,2020,doi:10.1177/2058739220946139http://dx.doi.org/10.1177/2058739220946139.
YU G Y,FANG D.Evaluation of neuraminidase inhibitory activity of compounds and extracts from traditional medicines by HPLC-FLD[J].Int J Anal Chem,2021,2021:6694771.
LIU J W,ZU M,CHEN K T,et al.Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines[J].BMC Complement Altern Med,2018,18(1):102.
ZHANG J J,LIU T,TONG X M,et al.Identification of novel virus inhibitors by influenza a virus specific reporter cell based screening[J].Antiviral Res,2012,93(1):48-54.
Protein Modification Omics: A Novel Approach Investigating Mechanisms of Chinese Medicines
Analysis of Chemical Composition and Fingerprint of Reference Sample of Xiao Xumingtang Based on UPLC-Q-TOF-MS/MS
Treatment of Diabetic Rats Mellitus-induced Erectile Dysfunction by Xiaoyaosan Based on Experiments
Structure-activity Omics of Anti-inflammatory and Analgesic Effect of Corydalis Rhizoma in Qizhi Weitong Granules
Structure-activity Omics on Anti-inflammatory and Analgesic Effect of Aurantii Fructus in Qizhi Weitong Granules
Related Author
WANG Lihan
HOU Jingyi
ZHANG Jingjing
YANG Hongjun
TIAN Zhenzhen
ZHANG Ziwei
SUN Jianhui
ZHAI Zhangxi
Related Institution
Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases,Experimental Research Center,China Academy of Chinese Medical Sciences
Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences
Tianjin University of Traditional Chinese Medicine,Tianjing
Beijing Increasepharm Co. Ltd.
Beijing Increasepharm Pharmaceutical Research Co. Ltd.